{"id":699543,"date":"2024-05-17T18:02:01","date_gmt":"2024-05-17T18:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=699543"},"modified":"2024-05-17T18:02:01","modified_gmt":"2024-05-17T18:02:01","slug":"hla-typing-for-transplant-market-size-analysis-growth-opportunities-top-manufacturers-share-trends-segmentation-regional-graph-and-forecast-to-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hla-typing-for-transplant-market-size-analysis-growth-opportunities-top-manufacturers-share-trends-segmentation-regional-graph-and-forecast-to-2028_699543.html","title":{"rendered":"HLA Typing for Transplant Market Size Analysis, Growth, Opportunities, Top Manufacturers, Share, Trends, Segmentation, Regional Graph and Forecast to 2028"},"content":{"rendered":"
\n
\"HLA<\/a><\/div>\n
\n
Browse 159 market data Tables and 42 Figures spread through 212 Pages and in-depth TOC on “HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, kits, software), Application (Antibody Screening), Type (Organ Transplant, Tissue), End User, and Region – Global Forecast to 2028<\/div>\n<\/div>\n<\/div>\n
HLA Typing for Transplant Market in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets\u2122<\/div>\n

HLA Typing for Transplant Market<\/a> in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing transplants volume worldwide, rising number of transplant & diagnostic centers, technological advancements, government initiatives to boost HLA typing services, rising public -private investments boost research in HLA genotyping, and increased focus of players to enhance their manufacturing & distribution capabilities across emerging countries are likely to support the growth of HLA typing for transplant market during the forecast period.<\/p>\n

Download an Illustrative overview: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=96374742<\/strong><\/a><\/p>\n

In the near future, HLA typing is poised to revolutionize the transplant industry. Rapid advancements in genomics and precision medicine will enable transplant professionals to intricately match donor and recipient HLA profiles, significantly reducing the risk of rejection and the need for immunosuppressive drugs. This breakthrough technology will expand the pool of potential donors, improve transplant success rates, and usher in a new era of life-saving organ and tissue transplantation, offering hope to countless patients awaiting these life-changing procedures.<\/p>\n

Key Market Players of <\/strong>HLA Typing for Transplant Industry:<\/strong><\/p>\n

Some of the prominent players in the HLA typing for the transplants market are Thermo Fisher Scientific (US) Illumina, Inc. (US), QIAGEN (Germany), CareDx (US),F. Hoffmann-La Roche Ltd. (Switzerland),Bio-Rad Laboratories, Inc. (US), Immucor, Inc. (US),  Luminex Corporation (US), TBG Diagnostics Limited. (Australia) FUJIREBIO (Japan),Omixon Inc. (US), GenDX (Netherlands), BAG Diagnostics GmbH (Germany), Creative Biolabs (US), and PacBio (US).<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=96374742<\/strong><\/a><\/p>\n

HLA Typing for Transplant Market Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n